MDalgorithms
PrivateLast Round
Seed
Aug 12, 2022
Est. Valuation
$1.71M
Total Funding Raised
$7.72M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MDalgorithms operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in August 2022.
MDalgorithms is a health-tech company that provides AI-powered dermatology solutions for skin and hair care through its brands MDacne and MDhair.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Medical AI, Telemedicine, Subscription Commerce, Fashion & Beauty
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MDalgorithms Comparables
Compare MDalgorithms with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dermala Inc. | 84% | |
| Honeydew | 81% | |
| Musely | 79% |
For institutional investors. Book with your work email.
MDalgorithms Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 12, 2022 | ||||
| Seed | Jun 1, 2022 | ||||
| Seed | Jan 22, 2018 | ||||
| Seed | Jun 1, 2017 | ||||
| Accelerator | Mar 21, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MDalgorithms Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed |
| Y Combinator | Seed, Accelerator |
| REDO Ventures | Seed |
| Moxxie Ventures | Seed |
| Moxxie Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Aug 12, 2025
Named to the 2025 Inc. 5000 list.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardNov 10, 2026
The 2026 Beauty Innovation Awards names MDalgorithms Inc. the winner of “Personalized Skin Care Product of the Year” for Nuvane and “Acne Treatment Innovation of the Year” for MDacne in its 8th Annual awards program in California on Nov 10th '26, recognizing innovative beauty products.
- recognized_asNov 10, 2026
MDalgorithms Inc. receives the “Personalized Skin Care Product of the Year” award for Nuvane and the “Acne Treatment Innovation of the Year” award for MDacne at the 8th Annual Beauty Innovation Awards in California on Nov 10th '26.
- receives_awardNov 10, 2026
MDalgorithms Inc. receives “Personalized Skin Care Product of the Year” for Nuvane and “Acne Treatment Innovation of the Year” for MDacne at the 8th Annual Beauty Innovation Awards in California on Nov 10th '26.
- recognized_asNov 10, 2026
The 2026 Beauty Innovation Awards, an independent recognition platform, names MDalgorithms Inc. the winner of Personalized Skin Care Product of the Year for Nuvane and Acne Treatment Innovation of the Year for MDacne in its 8th Annual awards program in California on Nov 10th '26.
- attends_eventNov 10, 2026
MDalgorithms Inc. wins "Personalized Skin Care Product of the Year" for Nuvane and "Acne Treatment Innovation of the Year" for MDacne at the 8th Annual awards program in California on Nov 10th '26.
For institutional investors. Book with your work email.
MDalgorithms Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MDalgorithms's valuation, stock price, and market status.
Is MDalgorithms a public or private company?
MDalgorithms is a private company.
What is the current stock price of MDalgorithms?
MDalgorithms is a private company, so its shares have no public market price. Caplight tracks MDalgorithms's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MDalgorithms worth (valuation)?
MDalgorithms's valuation is estimated at $1.7M based on funding round data.
Can I buy MDalgorithms stock?
MDalgorithms shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MDalgorithms's last funding round?
MDalgorithms's most recent funding round was Seed on August 12, 2022.
Who are the main investors in MDalgorithms?
Key investors in MDalgorithms include Y Combinator.
Will MDalgorithms IPO soon?
No public IPO plans have been announced for MDalgorithms.
How can I track MDalgorithms secondary market activity?
Caplight tracks bids, offers, and trades in MDalgorithms's shares on secondary markets.